Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
full blown rash; This spontaneous report was received from a physician and refers to a 14-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, dose, lot #, and expiration date were not reported) for prophylaxis. On an unknown date (also reported as the same date in the evening after receiving the vaccine), the patient experienced full blown rash. The patient recovered/resolved from the event of full-blown rash on an unspecified date. Nothing changed in the patient's diet other than receiving the Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9). The patient received a unknown antihistamine for the rash. The causal relationship between the event and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) was not provided. Lot # is being requested and will be submitted if received.